BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31197067)

  • 1. Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19.
    Plesa A; Labussière-Wallet H; Hayette S; Salles G; Thomas X; Sujobert P
    Haematologica; 2019 Oct; 104(10):e487-e488. PubMed ID: 31197067
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of CD19 and specific KIT-D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities.
    Wang B; Yang B; Ling Y; Zhang J; Hua X; Gu W; Yan F
    Cancer Med; 2021 Feb; 10(3):1091-1102. PubMed ID: 33382538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.
    Qu C; Li Z; Kang L; Wang Y; Dai H; Yin J; Chen G; Zhu M; Yao L; Xu T; Tian X; Xu Y; Chen J; Zhu X; Yu L; Wu D; Tang X
    Bone Marrow Transplant; 2019 Jul; 54(7):1138-1140. PubMed ID: 30631098
    [No Abstract]   [Full Text] [Related]  

  • 4. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
    Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H
    Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells.
    Danylesko I; Jacoby E; Yerushalmi R; Shem-Tov N; Besser MJ; Vernitsky H; Marcu-Malina V; Shimoni A; Avigdor A; Nagler A
    Leukemia; 2020 Jul; 34(7):1939-1942. PubMed ID: 31980731
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Immunophenotypical features of t (8; 21) (q22; q22) acute myeloid leukemia].
    Pan X; Li J; Xia X; Geng M; Wang A; Zhu M; Chen L; Guo Y; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jun; 22(6):313-5. PubMed ID: 11877092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of trisomy 6 in an adult acute myeloid leukemia with t(8;21).
    Choi J; Song J; Kim SJ; Choi JR; Kim SJ; Min YH; Park TS; Cho SY; Kim MJ
    Cancer Genet Cytogenet; 2010 Oct; 202(2):141-3. PubMed ID: 20875878
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myeloid leukemia with a novel t(8;21) variant: paracentric inversion-associated ins(21;8).
    Lee JH; Wan TS; Ha JS
    Leuk Lymphoma; 2014 Feb; 55(2):441-3. PubMed ID: 23672346
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia.
    Taguchi J; Miyazaki Y; Tsutsumi C; Sawayama Y; Ando K; Tsushima H; Fukushima T; Hata T; Yoshida S; Kuriyama K; Honda S; Jinnai I; Mano H; Tomonaga M
    Leuk Res; 2006 Sep; 30(9):1105-12. PubMed ID: 16457884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript variants of RUNX1T1: new insight into t(8;21)-positive leukemia.
    Kim JH; Ahn EY
    Leuk Res; 2014 Sep; 38(9):1018-9. PubMed ID: 25052308
    [No Abstract]   [Full Text] [Related]  

  • 11. AML1 and Pebp2: the gene for a transcription factor is involved in recurring translocations in human acute myeloid leukemia.
    Rowley JD
    Jpn J Cancer Res; 1994 Dec; 85(12):inside front cover. PubMed ID: 7852178
    [No Abstract]   [Full Text] [Related]  

  • 12. Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?
    Yoon S; Kim H; Hur M; Han SH; Chung HJ; Moon HW; Yun YM; Lee MH
    Int J Lab Hematol; 2019 Dec; 41(6):e145-e147. PubMed ID: 31050862
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudo-Chediak-Higashi anomaly in acute myeloid leukemia with t (8;21).
    Bozkaya IO; Yarali N; Sac RU; Tavil B; Kara A; Azik F; Tunç B
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):242. PubMed ID: 22441711
    [No Abstract]   [Full Text] [Related]  

  • 14. 8;21 and 15;17 translocations: abnormalities in a single cell lineage in acute myeloid leukemia.
    Knuutila S; Majander P; Ruutu T
    Acta Haematol; 1994; 92(2):88-90. PubMed ID: 7817709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia.
    Wimmer J; Hurstel R
    Blood; 2021 May; 137(18):2564. PubMed ID: 33956065
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
    Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
    Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
    [No Abstract]   [Full Text] [Related]  

  • 17. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement.
    Zoghbi A; Zur Stadt U; Winkler B; Müller I; Escherich G
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosome t (8; 21) and t (15; 17) in a patient with acute myeloid leukemia].
    Gao Y; Wang C; Xu L; Cao Q; Zhu Y; Cai Q; Yan S; Yang X
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):94-5. PubMed ID: 11877058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
    Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
    Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
    Yang G; Khalaf W; van de Locht L; Jansen JH; van der Reijden BA; Müller-Tidow C; Delwel HR; Serve H; Clapp DW; Hiebert SW
    Ann Hematol; 2004; 83 Suppl 1():S83. PubMed ID: 15124686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.